Janssen’s tuberculosis drug patent rejected, treatment likely to get cheaper – Scroll.in
Janssen’s tuberculosis drug patent rejected, treatment likely to get cheaper Scroll.in
In: PATENT NEWS
Janssen’s tuberculosis drug patent rejected, treatment likely to get cheaper Scroll.in
In: PATENT NEWS
HealthLynked new wireless technology patent adding more patient … Proactive Investors USA
In: PATENT NEWS
Aflibercept IPRs Update – Patent – United States Mondaq News Alerts
In: PATENT NEWS
Northann Corp Secures European Patent for Revolutionary 3D Printing Embossing Technology, Focused on Home Improvement Industry with Benchwick Subsidiary Yahoo Finance
In: PATENT NEWS
PTO Adds Green Energy Category To Patents For Humanity … Mondaq News Alerts
In: PATENT NEWS
Will Congress finally give the thumbs down to the Patent Trial and Appeal Board? Washington Examiner
In: PATENT NEWS
Patent law adds to this problem due to the protections available to patent holders that grants them the power to exclude oth-
In: PATENT NEWS
and the Journal of Intellectual Property Law & Practice (JIPLP), a publication of OUP. Since 2013, both journals have included a section in each issue …
In: PATENT NEWS
Following 10 years working in big pharma Nonny helped set up Alembia Intellectual Property, a boutique patent law firm specialising in the …
In: PATENT NEWS
In a recent case that provided more questions than answers, the court held that the “focus” of a provision of the Patent Act “is on the act of …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION